Review paper
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD
Abstract
Background Triple therapy combinations of a long-acting muscarinic antagonist (LAMA), a long-acting beta2-agonist (LABA), and an inhaled corticosteroid (ICS) for COPD were studied in randomized trials and observational studies, with variable results. We compared the effectiveness and safety of triple therapy with a LAMA-LABA combination in a real-world clinical practice setting. Methods We identified a cohort of patients with COPD during 2002...
Paper Details
Title
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD
Published Date
Apr 1, 2020
Journal
Volume
157
Issue
4
Pages
846 - 855
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History